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Abstract
Pyometra is a common and life-threatening disease in intact female dogs, which is 
generally treated by surgery. Early identification of dogs with high risk of 
complications or poor prognosis is valuable for optimising treatment and increase 
survival. The objectives of this thesis were to detect predictive markers for prognosis 
and outcome of pyometra by investigating clinical and pathophysiological responses 
and to explore the breed-dependent risk for pyometra and mammary tumours (MTs).
Leucopaenia was the most important predictive variable, associated with an 18-fold 
increased risk for peritonitis (present in 13% of the dogs) and an over 3.5-fold 
increased risk for prolonged postoperative hospitalisation. Fever or hypothermia was 
linked with an increased risk for peritonitis and dogs with moderate to severely 
depressed general condition or pale mucous membranes had an increased risk for 
prolonged postoperative hospitalisation. These results show that commonly explored
clinical variables may be helpful for predicting prognosis.
Blood concentrations of the acute phase proteins, C-reactive protein and serum 
amyloid A (SAA) were found to be increased in dogs with pyometra, whereas 
concentrations of albumin, insulin-like growth factor-I, and iron were decreased. 
Importantly, SAA concentrations were higher in the dogs that also suffered from sepsis. 
Though unspecific, SAA could therefore be a potential marker for identifying more 
severely affected dogs. The neuroendocrine protein chromogranin A was measured by 
its breakdown products catestatin and vasostatin. Catestatin concentrations were
decreased in pyometra whereas vasostatin concentrations did not differ compared to
healthy dogs. None of these investigated inflammatory mediators or chromogranin A
were useful for outcome prediction as measured by postoperative hospitalisation. 
The incidence of pyometra in 110 different breeds was studied using insurance data. 
Before 10 years of age, 19% of all female dogs had suffered from the disease. Breed
greatly affected the risk of both pyometra and MTs.
In summary, these findings show that clinical and laboratory data and analysis of 
inflammatory variables can be helpful for predicting prognosis and assessing severity in 
dogs with pyometra. Breed considerably affects the risk of pyometra and MTs, and the
information presented in this thesis will be valuable for evaluating possible health 
benefits of spaying in individual dogs, based on the risk of developing these diseases.
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1 Introduction 
1.1 Canine pyometra - general background 
Bacterial uterine infection (pyometra) is often described as the “major disease 
of female dogs” since it develops in more than 50% of all intact female dogs in 
certain breeds before 10 years of age (Egenvall et al., 2000a). The disease is 
characterised as a hormone induced uterine bacterial infection and 
inflammation, leading to a pus-filled uterus and systemic illness. 
Pyometra is potentially life-threatening and has deadly consequences if left 
untreated. Importantly, dogs with the disease often develop systemic 
inflammatory response syndrome (SIRS) (Fransson et al., 2007; Hagman et al.,
2007). SIRS is defined as a generalised inflammatory response which can be 
initiated by infectious as well as non-infectious insults, and where 
inflammatory mediators stimulate the cascade-like release of other mediators, 
which in excess can be harmful for the individual (Muckart & Bhagwanjee, 
1997). Sepsis i.e. “blood-poisoning” is defined as presence of SIRS caused by 
infection (Levy et al., 2003). Despite commonly inducing sepsis, the mortality 
rate in pyometra is relatively low, about 3-4% (Egenvall et al., 2001). In more 
severe cases, such as when shock has developed, the mortality rate increases to 
about 35% (Conti-Patara et al., 2012), and can be as high as 50% if peritonitis 
is present (Oelzner & Munnich, 1997).
Early diagnosis and treatment of pyometra is essential for increased chance 
of survival. Clinically useable markers for identifying high-risk patients and 
predicting outcome are currently in high demand. Several studies in both 
human medicine and veterinary medicine have investigated a variety of 
markers for monitoring treatment response or to predict outcome in different
diseases (Foushee et al., 2012; Zhang et al., 2008; Kosuge et al., 2007; Rau et 
al., 2007; Ceron et al., 2005; Claeys et al., 2002; Hogarth et al., 1997). Among 
such markers, analysis of inflammatory mediators in dogs with various 
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diseases is gaining interest within veterinary research (Christensen et al., 2014; 
Dabrowski et al., 2013; Kjelgaard-Hansen & Jacobsen, 2011; Klenner et al.,
2010).
The safest and most effective treatment of pyometra is surgical removal of 
the ovaries and infected uterus, i.e. ovariohysterectomy (OHE). 
Ovariohysterectomy is the same procedure as is commonly performed for 
elective spaying of female dogs, after which pyometra is prevented. In Sweden,
elective spaying was only performed in few dogs (7% in 1999, all ages)
(Egenvall et al., 1999) and though the proportion has been increasing lately to 
nearly 17% (Statistics Sweden, Sweden, 2012), most dogs remain intact (not 
neutered/spayed). In other countries, such as the USA, neutering/spaying is 
commonly performed to control the dog population and avoid a large number 
of unwanted stray dogs (Trevejo et al., 2011; Salman et al., 1998). The large 
proportion of intact Swedish dogs means that most female dogs are at risk of 
developing diseases associated with reproductive organs and hormones such as 
pyometra. Most Swedish dogs are insured, which is why data from insurance 
companies can be used to investigate the occurrence of diseases.  
The main insurance reimbursement claims due to costly veterinary care in 
female dogs in Sweden are treatment of pyometra and MTs (Egenvall et al., 
1999) with pyometra being the most frequent unique diagnosis in the female 
dog (Bonnett & Egenvall, 2010). Pyometra, and to some extent MTs, may be 
prevented by spaying, but OHE is also associated with some negative side-
effects such as urinary incontinence, fur alterations, behavioural changes, 
overweight, and increased risk for malignant tumours such as osteosarcoma 
and haemangiosarcoma (Smith, 2014; Zink et al., 2014; McGreevy et al.,
2005; Ru et al., 1998; Thrusfield, 1985). There are breed- and age-related 
differences in the occurrence of both pyometra and MTs, but the combined risk 
of developing these diseases has not yet been assessed (Egenvall et al., 2005; 
Egenvall et al., 2001). Risk factors for pyometra include nulliparity and 
hormonal therapy (oestrogen and progesterone) (Whitehead, 2008; Niskanen & 
Thrusfield, 1998; Borresen, 1979) whereas overt pseudo-pregnancy has been 
proposed as protective (Fidler et al., 1966). The effect of certain risk factors 
such as nulliparity may differ between dog breeds (Hagman et al., 2011).
1.1.1 Pathogenesis of pyometra
Although the development of pyometra has been the focus of many research 
studies over the years, the pathogenesis is still unclear (De Bosschere et al.,
2002; Millerliebl et al., 1994; Sandholm et al., 1975; Hardy & Osborne, 1974; 
Dow, 1959; Lesbouyries & Berthelon, 1936). The development is complex and 
the aetiology includes a combination of effects of hormone interaction,
12
virulence of the causative bacterial strains and counteracting defence 
mechanisms (Sandholm et al., 1975; Hardy & Osborne, 1974; Dow, 1959).
Progesterone plays an important role by stimulating proliferation and secretion 
of the uterine glands, decreasing contractions of the myometrium and 
diminishing the function of the immune response (Dow, 1959; Teunissen, 
1952). Endogenous or exogenous progesterone influences changes in the uterus 
which makes it suitable for foetal development, but such environment also 
facilitates intrauterine bacterial attachment and growth, creating optimal 
conditions for developing pyometra (Dow, 1959; Teunissen, 1952).
Progesterone-induced changes of the endometrium facilitate adherence of 
Escherichia coli (E. coli) to specific receptors in the endometrium, and 
probably contribute to the development of the disease (Sandholm et al., 1975).
Administrating oestrogen hormone alone does not induce pyometra in dogs 
(Dow, 1959). Oestrogen, however, enhances the effects of progesterone in its 
action which in turn may lead to development of the disease (Lessey et al.,
1981; Teunissen, 1952). In most pyometra cases (70-90%), E. coli bacteria are 
isolated from pyometra uteri (Hagman & Greko, 2005; Fransson et al., 1997).
As a natural inhabitant of the vaginal flora, E. coli enter the uterus during 
cervical opening in proestrus and oestrus (Watts et al., 1996). In healthy dogs, 
the defence mechanisms are able to eliminate the bacteria (Watts et al., 1996).
Two different classifications are used in many research studies of pyometra 
(De Bosschere et al., 2001; Dow, 1957). Based on histological changes of the 
uterus, Dow (1975) named the disease “the cystic endometrial hyperplasia 
(CEH)-pyometra complex” and classified it into four subtypes: (1) cystic 
hyperplasia (CEH), (2) cystic hyperplasia with acute endometritis, (3) cystic 
hyperplasia with plasma cell infiltration, and (4) chronic endometritis. The 
other classification was based on morphological and histological changes of 
the uterus together with reported clinical signs, dividing the disease into two 
entities, CEH-mucometra or endometritis-pyometra (De Bosschere et al.,
2001). Cystic endometrial hyperplasia is believed to predispose for 
development of pyometra, but CEH is generally not associated with clinical 
signs and may be present in middle-aged or older bitches without signs of 
disease (Dow, 1957). As a result, it is difficult to know how common CEH is 
in the dog population, and in how many of the cases with CEH, pyometra will 
follow, and how soon.  
1.1.2 Clinical presentation
Pyometra is commonly diagnosed in metoestrus/dioestrus, in middle-aged to 
older dogs, with mean age at diagnosis of 6-9 years (range; 9 months - 18 
years) (Niskanen & Thrusfield, 1998; Wheaton et al., 1989; Dow, 1957).
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Clinical signs depend on cervical patency, the severity of systemic 
inflammation and organ functions affected. Vaginal discharge, which is often 
odorous and sanguineous to muco-purulent, is considered a characteristic 
finding (Borresen, 1979). However vaginal discharge is only present in cases 
of open cervix pyometra, i.e. absent if the cervix is functionally closed, making 
diagnosis less clear in these cases. Other common signs of pyometra are more 
non-specific and include lethargy, depression, lack of appetite, polydipsia, 
polyuria and vomiting (Hagman et al., 2009b). Lameness is often present, but 
generally disappears after treatment of the pyometra (Klainbart et al., 2014).
1.1.3 Haematology and biochemistry variables
Common haematological changes in dogs with pyometra include leucocytosis, 
neutrophilia with a left shift and mild normocytic, normochromic, and non-
regenerative anaemia, which also can be observed in many other diseases 
(Bartoskova et al., 2007; Hagman et al., 2006; Fransson et al., 1997; De 
Schepper et al., 1987a; Borresen, 1979). Leucopaenia is less commonly found
(Borresen, 1980). Organ functions can be altered, including kidney and liver 
function, indicated by increased creatinine and blood urea nitrogen (BUN) 
concentrations, hypoalbuminemia and proteinuria (Maddens et al., 2011; 
Fransson et al., 1997; De Schepper et al., 1987b; Borresen, 1979). The 
impaired renal function might be due to tubulointerstitial inflammation or 
immune-complex associated glomerulonephritis resulting in glomerular and 
tubular dysfunction (Maddens et al., 2011; Heiene et al., 2007; Asheim, 1964).
Increased serum concentrations of alkaline phosphatase (ALP), bilirubin and 
cholesterol may indicate intrahepatic cholestasis which also has been suggested 
as a possible consequence of endotoxaemia (Sato et al., 2002; Borresen, 1980; 
Borresen & Skrede, 1980).
1.1.4 Diagnosis
The diagnostic workup in a dog with suspected pyometra usually includes 
retrieving disease and general history data from the dog-owner, physical 
examination, laboratory blood tests of haematology and biochemistry variables 
and diagnostic imaging by radiography and/or ultrasonography to demonstrate 
uterine enlargement. Abdominal ultrasonographic examination allows for 
accumulating uterine fluid content to be detected, even minor amounts, and 
CEH and signs of ovarian disease may also be visible. Ultrasonography is 
considered a reliable diagnostic imaging investigation for diagnosis of uterine 
disease associated with fluid accumulation, but because it depends on the 
equipment and skills of the examiner, it is not always possible to detect minor 
endometrial cysts (Bigliardi et al., 2004). Furthermore, accumulation of fluid 
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in the uterus is not always due to pyometra; it could also be caused by 
mucometra, hydrometra or haematometra, hence bacterial isolation and 
histopathological examination are necessary for accurate verification of the 
diagnosis. 
1.1.5 Treatment
Early diagnosis of pyometra and assessment of its severity is a prerequisite for 
optimal treatment decisions i.e. whether to perform immediate surgery as soon 
as the patient’s general condition is stabilized or if surgery can be delayed 
without risk for the patient.  
Surgical treatment
For several decades, the most effective treatment of pyometra has been 
considered to be surgical removal of the ovaries and uterus (OHE) (Rootwelt-
Andersen & Farstad, 2006), because it removes the site of infection and 
prevents disease recurrence. The OHE procedure is, however, not always life-
saving and it results in permanent infertility. Stabilization prior to surgery e.g. 
by intravenous fluid administration, adjusting electrolyte and acid-base balance 
and antimicrobial therapy is generally performed in severe cases to increase 
survival and prevent complications associated with sepsis such as bacterial 
emboli or shock (Conti-Patara et al., 2012). Antimicrobial drugs as sole 
treatment for pyometra are as a rule not considered completely curative.
Medical treatment
Purely medical treatment of pyometra is an option in selected cases such as for 
preserving fertility in a bitch with only mild disease condition or if surgery or 
anaesthesia is considered as associated with high risk for serious complications 
or death. Medical treatment protocols contain antimicrobial therapy 
administered in combination with drugs that induce cervical opening and 
emptying of the uterus and may include progesterone antagonists, dopamine 
agonists, prostaglandins or a combination of these drugs (Corrada et al., 2006; 
Fieni, 2006; Gobello et al., 2003). The reported recurrence rate is 19-48% but 
because the infected uterus is not removed, the risk of endotoxaemia and sepsis 
and associated complications remain during the treatment period (Ros et al.,
2014; Corrada et al., 2006; Fieni, 2006). The prognosis after medical treatment 
is more favourable in pyometra without CEH and ovarian cysts (Trasch et al.,
2003; Arnold et al., 1988) and in bitches of younger age (Jurka et al., 2010).
Combinations of antimicrobial therapy and intrauterine administration of 
betadine-saline (De Cramer, 2010) or prostaglandin FĮ (PGFĮ) (Gabor et al.,
15
1999), or intrauterine catheters (Funkquist et al., 1983) have been suggested as 
other non-surgical treatment alternatives for pyometra. 
1.2 Biomarkers - general background
One definition of a “biomarker” is “a characteristic that is objectively 
measured and evaluated as an indicator of normal biological processes, 
pathogenic processes, or pharmacological responses to therapeutic 
intervention” (Atkinson et al., 2001). Studies on biomarkers have gained 
growing interest in both human and veterinary medicine for various diseases 
and conditions, with the goal to find suitable biomarkers for early detection and 
diagnosis. Not only rapid change in levels of the biomarker when the disease 
develops is warranted, but also rapid normalisation during recovery, to allow 
its usefulness when monitoring the effects of therapeutic intervention. 
Additionally, sampling should be easy, the biomarker relatively stable, analysis 
reliable, quick, cost-effective and practical to perform cage-side. Predictive 
biomarkers are biomarkers that are valuable as objective tools for 
prognostication i.e. in the prediction of outcome and/or treatment response, and 
such biomarkers have been identified in a variety of human and animal 
diseases (Foushee et al., 2012; Eckersall & Bell, 2010; Gebhardt et al., 2009; 
Kosuge et al., 2007; Ceron et al., 2005). Markers or variables useful for 
prognostication can be derived from case history or physical examination 
parameters, results from inflammatory response and various other laboratory 
analyses or even other biological factors. 
1.2.1 Assessing the severity of pyometra
As mentioned earlier, pyometra leads to sepsis (SIRS) in more than 50% of 
dogs diagnosed (Hagman et al., 2009b; Fransson et al., 2007; Hagman et al.,
2007), and SIRS has been associated with prolonged hospitalisation (Fransson
et al., 2007). It is not only the bacteria per se that cause the severity of the 
disease but bacterial products such as endotoxin (ET), a potent inducer of 
inflammation, may contribute to a poorer prognosis. In one study of dogs with 
pyometra, higher blood concentrations of ET were associated with poor 
prognosis (death) (Okano et al., 1998). Hyperlactataemia has been associated 
with increased risk of mortality in other severely ill dogs suffering from other 
diseases (Stevenson et al., 2007; Nel et al., 2004). However, in dogs with 
pyometra, hyperlactataemia is generally mild and present only in a few dogs 
with unaffected circulation (Conti-Patara et al., 2012; Hagman et al., 2009b).
Disseminated intravascular coagulation (DIC) may develop in dogs with 
pyometra (Plavec et al., 2006). Other variables that have value for 
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prognostication include BUN and creatinine with increased concentrations 
being associated with higher risk of mortality (Kuplulu et al., 2009). The cause 
of death in dogs with the disese may also be due to cardiac malfunction.
Cardiac troponin I (cTnI), a marker for myocardial damage, has been found to 
be mildly to moderately increased in nearly half of the dogs diagnosed with 
pyometra (Pelander et al., 2008). Additionally, in one study highly increased 
cTnI postoperatively was found in a dog that died and that had myocarditis
(Hagman et al., 2007). In one study of dogs with sepsis or septic shock due to 
pyometra, higher central venous oxygen saturation (ScvO2) and lower base 
deficit was associated with a more favourable prognosis (low risk of death) 
(Conti-Patara et al., 2012).
1.2.2 Why biomarkers for sepsis in dogs with pyometra?
Sepsis, and especially severe sepsis which is defined as sepsis and dysfunction 
of one or more organs, remains an important and common cause of death in 
both human and veterinary intensive care units (Weiss et al., 2015; Kenney et 
al., 2010). Because the progression of pyometra to severe sepsis is potentially 
lethal, early recognition of sepsis and appropriate treatment is a prerequisite for 
treatment success and favourable outcome. Diagnosing sepsis is challenging 
because clinical signs and laboratory variables are generally unspecific, and 
reliable diagnostic markers are lacking (Borresen, 1979). Presence of bacterial 
infection and SIRS, established by certain clinical and laboratory criteria, is 
therefore currently used to identify patients with sepsis both in human and 
veterinary medicine (Kamisoglu et al., 2015; Hagman et al., 2009b; Fransson
et al., 2007; Otto, 2007; Afessa et al., 2001; Hauptman et al., 1997). SIRS can 
be initiated by several causes, i.e. viral infection, mechanical trauma, chemical 
agents, thermal injuries, radiation, immunological causes, ischaemia and 
necrotic tissue (Bone, 1992). Conventional diagnosis of sepsis through 
bacterial blood culturing can be time-consuming and antimicrobial sensitivity 
test results take additional time to obtain. In a study of septic human patients, it 
was found that antimicrobial treatment should be initiated within 6 hours, as 
the survival rate decreased by 7.6% for every hour that treatment was delayed 
(Kumar et al., 2006). Other studies have also shown that hospital mortality 
rates increase if administration of antimicrobials is delayed in septic human 
patients (Bloos et al., 2014; Dickinson & Kollef, 2011; Hounsom et al., 2011; 
Blanco et al., 2008). Biomarkers that could aid in the early detection of sepsis 
are thus valuable for optimising therapy and decreasing hospitalisation and 
mortality. In dogs, despite the benefits of antimicrobials with sepsis being 
currently debated (Keir & Dickinson, 2015), early detection and treatment 
initiation in sepsis is considered crucial for survival. Biomarkers that can be 
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helpful when selecting which patients should be treated with antimicrobials are 
urgently needed, because unnecessary or ineffective antimicrobial therapy will 
promote resistant bacteria and long-term increase of infections untreatable by 
commonly used drugs (Alanis, 2005).
In humans, concentrations of the acute phase proteins (APPs) C-reactive 
protein (CRP) and procalcitonin (PCT) are increased in sepsis and widely used 
as adjunctive tools to predict morbidity and mortality (Brunkhorst et al., 2000; 
Yentis et al., 1995). Other inflammatory mediators explored for this purpose 
include cytokines such as Interleukin-6 (IL-6) which is useful for diagnosis and 
prognostication in neonatal septic human patients (Kuster et al., 1998). In 
comparison to cytokines, the APPs are more stable and long-lasting in the 
circulation, which is advantageous for use as a biomarker (Dandona et al.,
1994). CRP and serum amyloid A (SAA) are major acute phase proteins in 
dogs (Ceron et al., 2005) and have been investigated for diagnostic and 
prognostic purposes in dogs with SIRS and sepsis (Chan et al., 2009; Gebhardt
et al., 2009; Fransson et al., 2007; Martinez-Subiela & Ceron, 2005). Blood 
concentrations of CRP increase in pyometra and to a higher extent if SIRS is 
present (Fransson et al., 2007).
Other biomarkers, such as catecholamines have been studied in human 
patients with sepsis, and it was shown that sympathetic nerve activities are 
stimulated in sepsis and caused increased release of catecholamines (Marchuk
et al., 1977). Studies in veterinary medicine of catecholamines as markers for 
sepsis in dogs, however, are still lacking.
C-reactive protein
The acute phase protein, CRP, discovered in humans in the 1930’s, is a major 
APP also in dogs (Yamashita et al., 1994; Tillett & Francis, 1930). C-reactive 
protein is produced by the liver (Hurlimann et al., 1966) when triggered by 
pro-inflammatory cytokines, foremost IL-6 (Yamashita et al., 1994) and has 
been used as a marker for systemic inflammation in studies of both humans and 
dogs (Ceron et al., 2005; Pepys & Hirschfield, 2003; Bigoszewski et al., 2001; 
Yamamoto et al., 1993). In humans, CRP is useful for prognostication, i.e.
prediction of survival rate and duration of hospitalisation and to evaluate the 
response of treatment (Pierce et al., 2009; Lobo et al., 2003; Philip & Mills, 
2000). In human patients, those with higher concentrations of CRP had worse 
outcome i.e. longer hospitalisation, higher risk of death, or non-responsiveness 
to treatment (Hogarth et al., 1997; Yentis et al., 1995). In veterinary medicine, 
increased serum CRP concentrations have been reported in various diseases 
(Christensen et al., 2014; Yamamoto et al., 1993) including dogs suffering 
from pyometra (Dabrowski et al., 2013; Fransson et al., 2007). However, CRP 
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concentrations increase in all diseases with systemic inflammation i.e. the 
increase is not specific for pyometra. 
Serum amyloid A
Serum amyloid A is another major APP in dogs and its production is induced 
by pro-inflammatory mediators (Ceron et al., 2005). Studies have investigated 
SAA in various diseases, in humans and animals, including dogs (Christensen
et al., 2014; Dabrowski et al., 2013; Zhang et al., 2012; Cho et al., 2010) and 
blood concentrations can be 800-fold increased during inflammation (Yule et 
al., 1997). In the uterus of dogs with pyometra, the gene for SAA is 
upregulated (Hagman et al., 2009c). The usefulness of SAA as marker to 
diagnose sepsis in dogs with pyometra has not yet been explored.
Albumin
Hypoalbuminaemia is a common finding in dogs with pyometra (Borresen & 
Skrede, 1980). Albumin is considered a negative acute phase protein. The 
production decreases during inflammation as a possible result of increased 
hepatic production of positive APPs and other inflammatory components (Liao
et al., 1986; Schreiber et al., 1982). Albumin concentrations have been shown 
to be a predictive marker in critically ill human patients, and also to be linked 
with malnutrition (Owen et al., 1993). Hypoalbuminaemia may be an effect of 
decreased albumin production but also and/or reflect increased vascular 
permeability in response to inflammation or infection (Deysine & Stein, 1980)
or increased loss via the kidneys (Levey et al., 2003). Furthermore, in humans 
with renal disease and who required haemodialysis, hypoalbuminaemia was 
associated with increased risk of mortality (Wetmore et al., 2008; Owen et al.,
1993). The value of albumin for prognostication in pyometra has not yet been 
explored.
Insulin- like growth factor-I
Insulin-like growth factor-I (IGF-I) is an anabolic peptide mediated by growth 
hormone which has many roles including control of cell proliferation, cell 
differentiation and anti-apoptosis (Heemskerk et al., 1999; Rodriguez-
Tarduchy et al., 1992). Several studies in humans have reported decreased 
concentrations of plasma IGF-I in response to infection and inflammation
(Heemskerk et al., 1999; Timmins et al., 1996). In endotoxaemia and chronic 
inflammation, IGF-I is downregulated, leading to decreased circulating IGF-I
concentrations, which has been interpreted as IGF-I being a negative 
inflammatory marker in rats and dogs (Tvarijonaviciute et al., 2011; Priego et 
al., 2003; Lang et al., 2000; Lopez-Calderon et al., 1999). Recently, one study 
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showed that concentrations of IGF-I decreased in dogs with pyometra prior to 
surgery and increased after surgery, in contrast to CRP (Dabrowski et al.,
2015). The role of IGF-I in dogs suffering from pyometra has not been 
thoroughly investigated. 
Iron
Plasma iron concentrations are regulated by the hormone hepcidin, originating 
from the liver. Production of hepcidin leads to decreased concentrations of iron 
in plasma (Nemeth et al., 2004). The production of hepcidin can be induced by 
cytokines e.g. IL-6 (Nemeth et al., 2003) and bacterial infection (Shike et al.,
2002). Studies evaluating iron concentrations in response to infection are rare 
in dogs (Konitzer et al., 1956), and to the author’s knowledge there has been 
no study focused on pyometra.
Chromogranin A (CgA)
Chromogranin A is a neuroendocrine secretory acid and water soluble protein 
that belongs to the granin family (Taupenot et al., 2003). CgA is one of three 
“classic” granins which include also chromogranin B and secretogranin II 
(chromogranin C). Chromogranin A was first isolated from chromaffin 
granules in the adrenal gland (Helle, 1966; Banks & Helle, 1965) and it can 
also be found in neuroendocrine and various neuron cells (Wilson & Lloyd, 
1984). CgA is co-released with catecholamines from chromaffin cells in the 
adrenal medulla by exocytosis (Oconnor & Bernstein, 1984) and is a precursor 
of several biologically active peptides. CgA has a various protease and 
peptidase cleavage sites and its breakdown products are named based on their 
different biological activities, e.g. catestatin (Cst; CgA361-372), vasostatin 
(VS; CgA17-38) and pancreastatin (Bartolomucci et al., 2011). The autocrine 
inhibitory effect of Cst to nicotinic acetylcholine receptor in the adrenal gland 
impedes secretion of catecholamines (Mahata et al., 2004). In addition, Cst 
induces proliferation, migration and anti-apoptosis in endothelial cells (Theurl
et al., 2010).
In humans, CgA measurement has been widely used as a marker for 
diagnostic and prognostic purposes in patients suffering from neuroendocrine 
tumours leading to increased CgA concentrations (Korse et al., 2012; Portela-
Gomes et al., 2010; Hsiao et al., 1990). Additionally, a high CgA 
concentration has been shown to be clinically useful for predicting severity and 
mortality in patients suffering from chronic heart disease (Angelone et al.,
2012; Ceconi et al., 2002). In severely ill non-surgical patients at an intensive 
care unit, higher CgA concentrations were detected in nonsurvivors compared 
to survivors (Zhang et al., 2008). Similarly, concentrations of CgA were shown 
20
to be higher in human patients who died of sepsis compared to those who 
survived (Rosjo et al., 2012).
There are a few published studies on CgA in dogs (Srithunyarat et al., 2014; 
Akiyoshi et al., 2005; Myers et al., 1997). In one study of dogs with acute 
stress, the results indicated that CgA concentrations increased in response to 
stress induced by insulin injection and it was concluded that CgA could be a
useful marker for stress (Akiyoshi et al., 2005). Additionally, increased plasma 
concentrations of CgA might be an indicator of suspected neuroendocrine 
tumours such as insulinoma (Myers et al., 1997). However, CgA has not yet 
been studied in dogs with sepsis or bacterial infection.  
1.3 Breed risk for pyometra and mammary tumours
Earlier studies have been performed to evaluate the incidence of pyometra 
(Egenvall et al., 2001) and MTs (Egenvall et al., 2005) in Sweden. These 
studies have some limitations because data from only two years and 30 dog-
breeds were included in the earlier pyometra study whereas, for MTs, data 
from an eight-year period and over 200 breeds were assessed. Information 
about the occurrence of pyometra is therefore missing for most dog breeds.
Additionally, the combined risk for developing the two most important 
diseases of the reproductive organs (pyometra and MTs) has never been 
investigated. Because neutering may affect the occurrence of both these 
diseases, it is valuable to evaluate the risk of both diseases combined by breed 
when deciding whether or not spaying may have some health benefits for a 
female dog. Possible health benefits and the risk for unwanted side-effects in 
each specific breed should be considered when assisting the dog-owners in 
making the optimal choice for their pet regarding neutering/spaying.
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2 Aims and hypotheses of the thesis
The objectives of this thesis were to investigate the clinical and 
pathophysiological responses to pyometra in dogs, to identify variables that are 
helpful for predicting outcome or severity of the disease, and to determine 
breed-dependent possible benefits of disease prevention by neutering. This new 
knowledge could increase the understanding of how findings from case history, 
clinical examination and laboratory testing and biomarkers can be helpful for 
assessing severity of the disease in each particular dog. 
¾ In Paper I, the hypothesis that case history data, clinical signs, and findings
on physical examinations or laboratory analyses may be useful for 
predicting peritonitis or outcome in pyometra bitches treated by surgery 
was tested.
¾ In Paper II, the hypothesis that concentrations of variables induced by the 
inflammatory response may be helpful in the diagnosis of pyometra or 
prediction of outcome was tested.
¾ In Paper III, the hypothesis that concentrations of inflammatory variables 
may be valuable for identifying sepsis in dogs with pyometra was tested.
¾ In Paper IV, the hypothesis that a neuroendocrine response is induced in 
pyometra and that associated variables may be valuable in the prediction of 
outcome was tested.
¾ In Paper V, the hypothesis that health benefits of spaying may differ 
between breeds as a result of the occurrence of two common diseases 
affecting the reproductive organs was tested.
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3 Materials and methods
A general description of the materials and methods used in the studies is 
presented here. For additional details, see Paper I -V (appendices).
3.1 Study designs
In Paper I, a retrospective study using data from dogs diagnosed with pyometra 
and treated at the University Animal Hospital (UDS), Swedish University of 
Agricultural Sciences (SLU) was designed. For Paper II-IV, prospective 
clinical studies with dogs diagnosed with pyometra and treated at the UDS, 
SLU, were designed. In Paper V, an epidemiological study using data from the 
Agria Insurance Company database was constructed including data from more 
than 260 000 female dogs enrolled in both veterinary care and covered by life 
insurance (the two types of insurances offered) during the years 1995-2006.
3.2 Ethical permission
The studies were approved by the Uppsala Local Ethical Board (permission 
number C413/12), and a signed informed consent was obtained from each dog-
owner before their dog participated, as described in Paper II-IV.
3.3 Animals
Study population/animals and data management
In Paper I, a retrospective study was carried out using data records from all 
bitches diagnosed with pyometra during the years 2006-2007 at UDS, SLU, 
Uppsala, Sweden. The bitches were identified by the diagnostic code for 
pyometra used in Sweden (Olson et al., 1993). In total 356 bitches were 
included in the study of which 315 were surgically treated, 9 purely medically 
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treated and 32 euthanised instead of treated after the diagnosis. The UDS’s 
patient records include data such as breed, weight, age, case history, findings 
on physical examination, results of radiographic and/or ultrasonographic 
examinations, laboratory analyses including haematology and serum 
biochemistry, treatments, date of leaving the UDS and follow-ups. The cases 
were generally admitted within two months of previous oestrus (in 
metoestrus/dioestrus). Exclusion criteria were parturition or pregnancy. All 
dogs had signs of systemic illness. The bitches were divided into three groups: 
1) euthanised dogs 2) medically treated dogs and 3) surgically treated dogs. 
Euthanasia was performed at the request of the owner and in agreement with 
the veterinary surgeon in charge, in most cases due to concomitant diseases and 
not because of a poor prognosis. Only bitches with normal hydration status, 
unaffected or slightly depressed general condition and with no ovarian or 
endometrial cysts demonstrated on ultrasonographic examination were selected 
for medical treatment with aglepristone (Alizin vet®, Virbac, Montpellier, 
France) in combination with antimicrobials (enrofloxacin, amoxicillin, 
ampicillin, cephalosporin, sulfadiazine and trimethoprim or 
amoxicillin/clavulanic acid), performed according to the routines at UDS. The 
success of the medical treatment was evaluated by ultrasonography and 
laboratory tests including haematology, total white blood cell counts (WBC)
and differential counts. Furthermore, data from the surgically treated bitches 
were analysed to explore possible indicators of pre-existing peritonitis or 
development of postoperative peritonitis or as predictors of dogs with 
subsequent prolonged postoperative hospitalisation. Intraocular pressure was 
measured in all bitches diagnosed with uveitis.
In Paper II-III, bitches admitted to UDS, SLU, Uppsala, Sweden, and 
diagnosed with pyometra were included in the studies. Thirty-one client-owned 
dogs with pyometra (Paper II and III) admitted to UDS, SLU, Uppsala, 
Sweden, during 2011, were included in the study prior to surgical treatment 
(OHE). Additionally, 17 healthy female staff-owned dogs of similar weight 
and in a comparable stage of the oestrus cycle were enrolled as the control 
group (Paper II).
The preliminary diagnosis pyometra was based on case history, and results 
of physical examination and diagnostic imaging by ultrasonography or 
radiography or both to demonstrate an enlarged, fluid-filled uterus. The 
presumptive diagnosis pyometra was further indicated by visual inspection 
during OHE and later confirmed by postoperative macroscopic and 
histopathological examination of the uterus and ovaries performed at the 
Department of Biomedical Sciences and Veterinary Public Health, SLU, 
Uppsala, Sweden and bacterial cultures and sensitivity tests were performed at 
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an accredited laboratory, Section of Bacteriology, National Veterinary Institute 
(SVA), Uppsala, Sweden. Bitches with solely cystic endometrial hyperplasia, 
mucometra, hydrometra, haematometra or endometritis were not included in 
the study. 
In general, bitches subjected to OHE due to pyometra at UDS are 
hospitalised 1-2 days after surgery. Prolonged postoperative hospitalisation 
GHILQHGDVGD\VLVZDUUDQWHGLIVSHFLILFFRPSOLFDWLRQVRFFXURU the general 
condition of the bitch is moderately or severely depressed and additional 
veterinary care and monitoring required (considered an unspecific 
complication in the investigation). 
In Paper IV, in total 114 bitches were included, including 50 with pyometra 
of 23 breeds, and 64 healthy bitches of 22 breeds. All bitches with pyometra 
were treated by OHE at the UDS, SLU, during the study period 2009-2013. A
complete physical examination was performed by the veterinarian in charge, 
and the results recorded in a special form. The preliminary diagnosis of 
pyometra was based on case history data, findings on physical examination,
laboratory test results, and diagnostic imaging by either abdominal 
ultrasonography or radiography or both. 
In Paper V, data from more than 260 000 dogs insured during the years 
1995-2006 was downloaded to a personal computer. All dogs included in the 
analyses were less than 10 years old. The variables used were: sex, breed, date 
of birth, date of death, postal code, dates when dogs entered or left the 
insurance programme and information on the type of insurance for which dogs 
were enrolled, insurance claims or reimbursement. Diagnostic codes, assigned 
by the attending veterinarian, were also downloaded. These codes were 
assigned based on a hierarchically constructed diagnostic registry with 
approximately 8 000 codes (Olson et al., 1993). If dogs left the insurance 
during a year for reasons other than the evaluated diseases, they were regarded 
as censored (leaving the database during the year of analysis). For example, in 
the 12-month risk calculations (see below) censored dogs only contribute a "½-
dog" to the denominator instead of a whole dog for the non-censored dogs.
Many dogs originally insured before 1995 had only the year of birth 
accurately recorded. These dogs were considered to have been born the 2nd of 
July the respective year. For analyses that required dogs to be assigned to age 
categories, these were assigned based on the age of the dog on the 1st of 
January 1995-2006 respectively (< 1, 1 < 2, ..., 9 < 10 years). Breeds were 
classified according to the Swedish Kennel Club breed classification system 
and some breeds were combined because they were considered to be the same. 
For example, "Dachshund miniature" included all miniature variants, 
"Dachshund normal-size" included all except long-haired Dachshunds, 
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"German Pointer" included both smooth-haired and wire-haired, and "Poodle" 
included Miniature and Toy Poodles. The breed varieties mentioned are 
considered to have a shared gene pool because there are no strict barriers for 
breeding between the varieties.
Veterinary care insurance has no age limit and reimburses the owner most 
of the fee if the dog receives costly veterinary care. Dogs can also be life-
insured, but only up to 10 years of age. With life insurance, the owner 
generally will be reimbursed if the dog dies or is euthanised. Whether the dog 
died or was euthanised cannot be differentiated in the database. Most insured 
dogs have both types of insurance. The insurance process has earlier been 
described in detail (Egenvall et al., 2000b).
3.4 Laboratory analyses
3.4.1 Haematology, biochemistry and hormonal analyses
Blood samples for haematology, serum biochemistry and hormonal analyses 
were collected from the distal cephalic vein and transferred into EDTA and 
non-additive collection tubes (Vacutainer®, Becton-Dickinson, Stockholm, 
Sweden), respectively. The non-additive tubes were placed on ice, centrifuged 
and serum separated before analysis.  
Haematological (WBC including differential counts, haematocrit (EVF) and 
haemoglobin (Hb)) and biochemical (bile acids, alanine aminotransferase 
(ALT), glucose, blood urea nitrogen (BUN), and creatinine) analyses were 
performed using Advia 2120; Siemens Healthcare Diagnostics, Deerfield, IL, 
USA for haematology and Abbott Architect c4000, Abbott Park, IL, USA, for 
biochemistry (Paper I- IV). 
Albumin was analysed with a colorimetric method (bromocresol green) 
using an automated analyser (Abbott Architect c4000, Abbott Park, IL, USA) 
with a commercial albumin reagent from Abbott Laboratories (Paper I-IV). 
Progesterone analyses were performed using an enhanced 
chemoluminescence immunoassay (Immulite, Diagnostic Products 
Corporation, Los Angeles, CA, USA). The oestrous cycle stage was defined by 
vaginal cytology and progesterone analysis (Paper II). 
Haematological and biochemical analyses were performed according to 
routine methods at the Clinical Pathology Laboratory, UDS, SLU, Uppsala, 
Sweden.
3.4.2 Acute phase proteins and other inflammatory markers
Analysis of CRP was performed with a human immunoturbidimetric test 
previously validated for dogs (Randox Laboratories Ltd, Crumlin, UK) 
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(Klenner et al., 2010; Kjelgaard-Hansen et al., 2003). The analyses were
performed on Abbot Architect (Abbott Architect c4000, Abbott Park, IL, USA) 
and the method was calibrated with canine CRP (Life Diagnostics canine CRP, 
West Chester, USA). The lowest measurable concentration was 5 mg/L with 
mean intra- and interassay variations of 1.4% and 2.4%, respectively. Samples 
with high concentrations of CRP (above 217 and 225 mg/L for the two lots 
used) were autodiluted 1:3 with 0.9% NaCl and reanalysed to obtain exact 
values (Paper II, III and IV).
For SAA, the analyses were performed using a commercially available 
ELISA (Tridelta PhaseTM Range SAA Assay, Tridelta Development Limited, 
County Kildare, Ireland), with mean intra- and inter-assay coefficients of 
variation of 4.75% and 8.8%, respectively, and with the lowest measurable 
concentration of 10 mg/L. The absorbance was evaluated using Tecan Sunrise 
reader (Tecan Inc., Männedorf, Switzerland). The method has previously been 
validated for dogs (Martinez-Subiela & Ceron, 2005) (Paper II and III). 
An IGFBP-blocked ELISA (Mediagnost, Reutlingen, Germany), validated 
for use in dogs, was used for evaluation of IGF-I concentrations, with intra-
and inter-assay coefficients of variation of less than 10%, and the lowest 
measurable concentration of 22 ng/mL (Strage et al., 2014; Strage et al., 2011)
(Paper II). 
Measurement of iron concentrations was performed by direct colorimetric 
determination (Abbott Laboratories Inc., Illinois, USA) with a detection limit 
of 0.9 mol/L (Paper II). 
All laboratory tests for inflammatory variables were performed according to 
the manufacturer’s instructions by trained laboratory staff at the Clinical 
Pathology Laboratory, UDS, Uppsala, Sweden (Paper I, II, and III). 
The break-down products derived from CgA- Cst and VS- were measured 
in heparinised plasma by radioimmunoassays specific for Cst and VS 
(Stridsberg et al., 2004; Stridsberg et al., 2000). These assays have been 
described in detail in a previous study and are in-house assays performed at the 
Research Department of Clinical Chemistry, Uppsala University Hospital, 
Sweden (Stridsberg et al., 2004). The method has been evaluated for use in 
dogs (Stridsberg M et al., 2014).
3.4.3 Bacterial isolation
Samples were immediately collected from the uterine content of the removed 
uterus with sterile fibre cotton swabs (Culturette; Becton-Dickinson AG, 
Stockholm, Sweden). Bacterial cultures and sensitivity tests were performed at 
an accredited laboratory, Section of Bacteriology, SVA, Uppsala, Sweden as 
described earlier (Hagman et al., 2009a) (Paper III). 
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3.5 Data analyses
3.5.1 Paper I
Univariable associations between potential risk factors within case history, 
physical examination and laboratory data and the outcomes prolonged 
hospitalisation and signs of peritonitis, respectively, were analysed by Chi-
Square test and Fisher’s exact test. Multivariable associations between 
potential risk factors and the outcomes were analysed by logistic regression 
models. All variables with a p-YDOXH LQ WKHXQLYDULDEOH DQDO\VHVZHUH
considered as potential predictor variables. Categorical predictor variables 
were introduced in the models coded as dummy variables. Collinearity between 
potential predictor variables were assessed by Spearman rank correlation and 
considered present when |r| > 0.6, in which case the variable with a) least 
missing values or b) providing the best model fit was retained. Modelling was 
done manually by backward elimination of non-significant (P > 0.05) 
variables. At each step, previously eliminated variables were tested for re-
entry. Confounding was assessed by comparing the change in estimated 
coefficients when variables were excluded from the model, and were 
considered present if a coefficient changed > 20%. The statistical models were 
developed separately with and without variables related to laboratory data 
because of many missing observations. All statistical analyses were performed 
using SAS (version 9.3, SAS Institute Inc., Cary, NC, USA).
3.5.2 Paper II
The program SAS 9.2 for Windows version 6.1.7601 (SAS Institute Inc. Cary, 
NC, USA) was used for statistical analyses. Student’s t-test and Analysis of 
Variance (ANOVA) were used for normally distributed variables, and Van der 
Waerden Two-Sample test was used for variables when most healthy bitches
had concentrations below the lowest measurable concentration (i.e. for CRP 
and SAA, levels were set to half the lowest measurable concentrations (5 mg/L 
and 10 mg/L, respectively, for the analyses). Pearson’s product moment 
correlation coefficient was used for analyses the association of variables and 
duration of postoperative hospitalisation. Significance level was set to P < 0.05 
for all tests in the study.
3.5.3 Paper III
All statistical analyses were performed using of SAS 9.3 package (SAS 
Institute Inc. Cary, NC, USA). ANOVA was used to evaluate the differences of 
SAA, CRP and albumin between septic and non-septic groups and to 
investigate a possible relation between inflammatory markers and morbidity as 
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measured by increased postoperative hospitalisation. Residual diagnostic plots 
were used to assess normality and homoscedasticity.
The diagnostic power of different markers was assessed using logistic 
regression (Olsson, 2002). The area under curve (AUC) was used as a measure 
of diagnostic ability. The cut-off value was selected as upper 5% limit in the 
non-septic group (Pape, 2003).
Descriptive data were described as mean ± SE. Bitches with concentrations 
below the lowest measurable concentration were assigned a value of half that 
value for the statistical analyses. 
3.5.4 Paper IV
Statistical analyses were performed by using Minitab software programmes for 
Windows version 16 (Minitab Inc., State College, PA, USA). After checking 
that data were normally distributed, Student’s t-test was used to test differences 
of haematology, biochemistry, Cst and VS between the control and pyometra 
group. The different concentrations of Cst and VS in pre- and postoperative 
samples were compared by using the paired t-test. In control dogs that had 
concentrations of CRP lower than 5 mg/L, the concentration was set to half the 
lowest measurable concentration (2.5 mg/L) for the statistical analyses. A 
Wilcoxon two-sample test was used for analysis when most control bitches had 
CRP concentrations below the lower measurable concentration. In the 
pyometra dogs, Pearson’s correlation was used to evaluate associations 
between Cst and VS and other variables- including age, weight, haematology, 
biochemistry, concentration of CRP, and duration of hospitalisation. Pearson’s 
product moment correlation coefficient was also used to investigate 
associations between Cst and VS in heparinised and EDTA plasma. The p-
value was set at P < 0.05 for all tests used.
3.5.5 Paper V
Few bitches in Sweden are spayed electively. It was assumed, for the sake of 
this study, that none were electively spayed and accordingly that all insured 
bitches were at potential risk of developing pyometra, if not already having 
done so. If dogs had reimbursed claims for pyometra for veterinary care and/or 
life they were considered as pyometra cases. For life claims they were 
considered as cases irrespective of whether reimbursed or not. From the 
information in the database it could not be seen whether dogs claimed for life 
insurance died or were euthanised. Only reimbursed veterinary care events 
were included because the non-reimbursed group was not homogenous. Some 
people submitted all claims and others submitted only those that have a 
reasonable chance of being reimbursed. Almost all claims for pyometra and 
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MT however, were submitted and reimbursed. Accordingly, it was assumed 
that whether or not non-reimbursed claims are included should not make a 
quantitative difference.
Using data on all bitches < 10 years of age and covered by insurance both 
for life and veterinary care, the crude and breed-specific median ages were 
calculated and the crude and breed-specific median ages at development of 
pyometra and MTs were determined.
Dogs entering during a year (i.e. enrolling in insurance after January 1st)
were not included in the analysis of that year. As few Swedish bitches are 
neutered/spayed and because neuter status was not included in the database, it 
was decided to adjust the number of dogs at risk in each age group (Egenvall et 
al., 2001).
Age- and breed-specific adjusted 12-month risks were used to estimate the 
cumulative crude and breed-specific risk of pyometra and MTs in each age 
category, using a combined risk formula: total risk in n age category = 1- (1-
risk age category <1)*(1-risk age category 1<2 )*…*(1-risk age category n)(Kleinbaum et al.,
1982). One minus the total risk was considered as the proportion that had, at 
that age, not yet developed pyometra (or MT, i.e. "the survival to pyometra or 
MT". The statistical software programme SAS (SAS Institute, Cary, NC) was 
used to analyse the data, and the procedure GENMOD used for the logistic 
regression.
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4 Results and discussion
4.1 Pyometra - a common and life-threatening illness
On average, nearly one-fifth of all Swedish female dogs (19%) were diagnosed 
with pyometra before 10 years of age. In 10 of the studied breeds, a proportion 
of 50% or more of the bitches had been diagnosed with the disease by the age 
of 10 years (Paper V). These results show that pyometra remains a common 
diagnosis and that the disease is an important illness. The proportion of dogs 
overall affected by the disease was slightly lower than what has been reported 
earlier (23-24%), which probably depends on the fact that more breeds of low-
risk were included in the present analyses (Egenvall et al., 2001).
In many dogs with pyometra, the clinical signs are classic and the diagnosis 
straight-forward, but in some dogs the diagnosis can be more difficult because 
of diffuse clinical signs. In dogs with closed cervix pyometra, i.e. without 
vaginal discharge, the signs are less clear. The most common case history and 
clinical signs reported (in Paper I/III, respectively) were vaginal discharge 
(77%/65%) anorexia (69%/74%), depression (63%/100%), polydipsia 
(62%/45%) and polyuria (60%/42%). These findings illustrate the local and
systemic effects of the disease (Hagman, 2012; Wheaton et al., 1989; Borresen, 
1979; Dow, 1957).
Ovariohysterectomy is considered the safest and most efficient treatment 
method for pyometra and most dogs are surgically treated, i.e. 315 of 356 dogs 
(Paper I). Only four of the surgically treated dogs died postoperatively leading 
to a mortality of 1% in these dogs. This is lower than the 5-27% mortality in 
previous reports (Kuplulu et al., 2009; Hagman et al., 2007; Wheaton et al.,
1989). The relatively low mortality could reflect that the disease is common 
and thereby recognised quickly in Sweden enabling appropriate treatment to be 
initiated early in the disease progression. Rapid initiation of treatment might 
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reduce the presence of severe complications result in shorter duration of 
hospitalisation and increase the survival rate in dogs with pyometra. 
The different causes of mortality in the surgically treated dogs were 
unknown (2 dogs), splenic rupture (1 dog) and severe peritonitis (1 dog). As 
the disease is more common in bitches of middle-aged to older age, concurrent 
diseases may be present. Euthanasia instead of treatment was performed in 32 
dogs (9%) (Paper I), not because of a poor prognosis of the pyometra treatment 
but by request from the owner and in agreement with the veterinary surgeon in 
charge due to concomitant diseases including severe hip dysplasia (n = 1), 
hepatic disease associated with ascites (n = 1), long-term polyuria/polydipsia 
(n = 1 ), several other diseases (n = 2), kidney malfunction (n = 1), MT (n = 1), 
multiple neoplasia in oesophagus (n = 1), or due to pyometra associated with 
old age of the bitch (n = 24). If the 32 euthanised dogs were included, the total 
mortality rate in dogs with pyometra was about 10% (36/356 bitches). 
The severity of pyometra was also shown by the presence of complications 
(Paper I).  
In total, specific complications were observed in 25% (n = 78) of the 315 
surgically treated bitches. The most frequently observed complication was 
peritonitis (40 bitches), followed by urinary tract infection (19 bitches), wound 
infection (8 bitches), uveitis (6 bitches), and cardiac arrhythmia (5 bitches). 
Thus, although the mortality is relatively low, complications develop in one-
fourth of surgically treated dogs. The most common complication was 
peritonitis which is serious and can be life-threatening, further indicating the 
severity of the disease and the urgency for early diagnosis and treatment. 
Postoperative hospitalisation after surgical treatment of pyometra is 
generally 1-2 days at UDS, unless specific complications are present or the 
overall health status indicates that further monitoring and treatment is 
necessary. Prolonged postoperative hospitalisation (here estimated three or 
more days), considered as a non-specific complication, was observed in 19% of 
the cases (60/315 bitches) (Paper I) and 39% (12/31 bitches) (Paper II), 
respectively. In spite of pyometra being linked to a relatively low mortality, the 
increased postoperative hospitalisation observed in about 20-40% of the cases 
clearly shows the severity of the disease. If complications were possible to 
detect early or if it was possible to predict bitches at risk of becoming more 
severely affected than others, this would be highly valuable for providing early 
and optimal treatment that in turn would increase survival and potentially 
fewer dogs requiring prolonged postoperative hospitalisation. 
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4.2 Clinical parameters are helpful in the prediction of outcome 
in surgically treated dogs
Among the haematology variables analysed, neutrophilia (55.3%), leucocytosis 
(54.3%) and monocytosis (50.7%) were the most common findings in dogs 
with pyometra and present in more than 50% of the dogs (Paper I). These
alterations are considered typical for the disease and the proportions are about 
the same magnitudes as reported previously (Fransson et al., 1997; De 
Schepper et al., 1987a). Concentrations of bile acids and albumin were lower 
in dogs with pyometra than in healthy dogs (Papers II and IV). 
Hypoglycaemia was associated with both prolonged postoperative 
hospitalisation and peritonitis in surgically treated dogs (Paper I). The finding 
that hypoglycaemia has predictive value is in agreement with the results of a 
study of septic human patients, showing that low blood glucose was associated 
with a high risk of mortality in sepsis caused by E. coli (Alamgir et al., 2006).
However, as there were only few dogs with hypoglycaemia in the present 
study, these results should be interpreted with some caution and will need to be 
investigated further.
Decreased concentrations of iron were commonly found in pyometra (Paper 
II). It has been shown in mice that subcutaneously injected turpentine oil led to 
an inflammatory response and subsequently decreased circulating iron (Nicolas
et al., 2002). A similar study performed in dogs with injected turpentine or 
staphylococci, also led to decreased iron concentrations even before anaemia 
had developed (Gbeenberg et al., 1947). Iron could perhaps be used as a 
negative marker for diagnosis of diseases associated with inflammation or 
infection, but further studies of its value as a possible biomarker are necessary. 
In Paper I, medical treatment was chosen for nine dogs (2.5%). These
bitches were treated with aglepristone in combination with antimicrobial 
therapy administered for a mean duration of 23 days. Regarding antimicrobial 
therapy, one fifth (n = 65) of all the dogs with pyometra (Paper I) had been 
treated prior to presentation at UDS. Of these, five dogs were not treated with 
antimicrobials because of pyometra but because of other disorders (dermatitis
in one dog, cystic calculi in one dog, cystitis in two dogs, and arthritis in one 
dog). In 124 (35%) of the 315 surgically treated bitches, antimicrobials were
administered postoperatively. During the past decades, the increasing threat of 
antimicrobial resistant microbes has become a major problem in both humans 
and animals. In Sweden, indications for antimicrobial therapy in pyometra are 
moderately to severely depressed general condition, high risk of or signs of 
sepsis or specific complications associated with disseminated infection, and
antimicrobials are thus not administered to all bitches with the disease. 
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However, antimicrobials are more widely used in other countries (Adamovich-
Rippe et al., 2013; Dabrowski et al., 2013; Kum et al., 2013). Further studies 
of antimicrobial therapy and possible additional restrictions are warranted for 
optimising medical and surgical treatment routines at the same time as 
reducing the likelihood of antimicrobial resistant bacteria developing.
In Paper I, the risk of prolonged postoperative hospitalisation was 
investigated in relation to different clinical signs, physical examination 
findings and laboratory data. The results showed that vomiting, severe 
depression, pale mucous membranes, severe dehydration, abdominal pain on 
palpation, leucopaenia, neutropaenia, monocytopaenia, increased serum 
creatinine, hypoglycaemia and increased lactate concentrations were associated 
with prolonged hospitalisation. However, some parameters were analysed in 
only a few of the bitches for example lactate (n = 19); hence, missing data was 
a limitation for thorough evaluation of these variables.
Peritonitis was the most common complication in bitches with pyometra 
undergoing surgical treatment, present in about 13%, whereof one dog died 
postoperatively. Furthermore, 12 out of the 40 surgically treated dogs with 
peritonitis required prolonged postoperative hospitalisation. In pyometra, 
peritonitis may be caused by leakage of pus from the ovarian bursa (Rubio et 
al., 2014) or uterine rupture. Septic peritonitis is associated with a high risk of 
death with reported mortality rates of 30-70% in dogs (Lanz et al., 2001; 
Mueller et al., 2001; Ludwig et al., 1997). The mortality in dogs with 
peritonitis was lower in the present study (<1%) and also compared to a
previous study in which 50% of dogs with pyometra diagnosed with peritonitis 
died (Oelzner & Munnich, 1997). These results indicate that if treated 
appropriately, the prognosis is more favourable in peritonitis caused by 
pyometra than earlier reported. The reason for the difference between studies 
of pyometra is unknown but could depend on the disease being well-known in 
Sweden, with a widespread knowledge of optimal treatment routines and 
possible complications detected at an early stage. There could also be a 
difference in severity of the peritonitis in the studied dogs. 
Several potentially useful predictive markers among the routinely analysed 
laboratory and clinically registered parameters were found in the 356 bitches 
with pyometra in Paper I. Leucopaenia was demonstrated in seven of the 
surgically treated dogs and in six out of these (85%) the postoperative 
hospitalisation was prolonged which indicates a more severe disease. In bitches 
with leucopaenia there was an 18-fold increased risk of being diagnosed with 
peritonitis and 3.5-fold increased risk of needing prolonged postoperative 
hospitalisation. Although few dogs (only 8) had leucopaenia, these results 
clearly indicate that leucopaenia is a sign to consider when evaluating the 
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severity of pyometra. That leucopaenia can be associated with increased 
severity in pyometra, is in line with leucopaenia also being associated with 
increased risk of mortality in septic humans (Afessa et al., 1995; Hook et al.,
1983).
4.3 Inflammatory variables may be helpful in the diagnosis and 
prediction of outcome
Despite concentrations of CRP being significantly increased in pyometra 
(Paper II and III), CRP was not valuable as a marker to identify sepsis as the 
concentrations did not differ between septic and non-septic dogs. Furthermore, 
CRP was not associated with prolonged hospitalisation (Paper II and III) in 
contrast to what has been reported previously (Fransson et al., 2007). The
differences between studies could reflect that the present study included fewer 
dogs because otherwise sampling methods and patient inclusion criteria were 
similar. Increased concentrations of CRP have been associated with increased 
mortality in dogs with SIRS and sepsis (Gebhardt et al., 2009), but this 
association could not be investigated here as none of the dogs in which CRP 
was measured died. Serum amyloid A was another APP studied and increased 
concentrations of SAA were found in dogs with pyometra (Paper II and III). 
This finding is in agreement with increased SAA concentrations demonstrated 
also in two other studies (Christensen et al., 2014; Dabrowski et al., 2007).
Exclusively dogs with pyometra had SAA and CRP concentrations over the 
lowest measurable concentration (5 and 10 mg/L, respectively) (Paper II and 
III). It was therefore possible that CRP and SAA could be useful in
differentiating dogs with pyometra from healthy dogs, when used in 
combination with other findings. However, it should be noted that one dog 
with pyometra had CRP and SAA concentrations below the lowest measurable 
concentration (Paper II). Considering that the APPs increase in all diseases 
associated with systemic inflammation and that pyometra did not always lead 
to increased concentrations, the diagnostic value of either APP for pyometra is 
therefore limited. In dogs with pyometra and sepsis, the number of band 
neutrophils, monocytes and basophils were significantly higher than in dogs 
without sepsis (Paper III). Because WBC and band neutrophils were used to 
classify dogs with SIRS in our study, these variables and those closely linked, 
were not independent and therefore not useful as markers to identify sepsis.
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4.4 Novel variables for inflammation and stress – possible 
markers for prognostication of disease?
4.4.1 Insulin-like growth factor-I
In Paper II, it was shown for the first time that IGF-I concentrations are lower 
in bitches with pyometra than in healthy bitches. These results are confirmed in 
another more recent study of dogs with the disease (Dabrowski et al., 2015).
Mean IGF-I concentrations (± SE) in dogs with pyometra were 221.2 ± 22.5 
ng/mL and in healthy dogs 366.7 ± 46.2 ng/mL. The findings are also in 
agreement with a previous study where systemic IGF-I concentrations 
decreased in response to chronic inflammation (De Benedetti et al., 1997).
However, other factors such as age, gender, nutrition status and diseases such 
as diabetes mellitus, could influence concentrations of IGF-I in the circulation 
(Chestnut & Quarmby, 2002; Heemskerk et al., 1999; Juul et al., 1994), which 
should be considered in further investigations of the use of this parameter to 
detect inflammation or infection. Furthermore, body size and age in dogs have 
been associated with the IGF-I levels i.e. a positive correlation with body size 
and a negative correlation with age was shown (Greer et al., 2011; Eigenmann
et al., 1988). In the present study, the body weight was similar in the disease 
and control groups, and they could therefore be compared. However, the age 
difference cannot be excluded as possible confounder for the difference in IGF-
I levels between the two groups. Moreover, IGF-I concentrations in dogs have 
been shown to decrease with restricted energy intake (Maxwell et al., 1998).
Most pyometra dogs had decreased appetite at admission, which is why low
food intake also may have contributed to the lower serum IGF-I 
concentrations. Additionally there might be unknown breed differences to 
consider.
4.4.2 Chromogranin A
In Paper IV, two break-down products, Cst and VS, derived from CgA, were 
measured with methods recently evaluated for use in dogs (Stridsberg M et al.,
2014). Concentrations of Cst (mean ± SE) in the pyometra group were 
significantly lower (1.0 ± 0.05 nmol/L) compared to the healthy group (1.7 ± 
0.03 nmol/L). Meanwhile, concentrations of VS did not differ between the two 
groups (mean ± SE, 0.40 ± 0.04 and 0.42 ± 0.30 nmol/L in pyometra dogs and 
healthy dogs, respectively). Concentrations of Cst and VS did not differ when 
comparing samples obtained before surgery (mean ± SE 0.89 ± 0.07 nmol/L 
for Cst and 0.36 ± 0.04 nmol/L for VS) and after surgery (Cst 0.86 ± 0.04 
nmol/L and VS 0.36 ± 0.04 nmol/L). This study is the first report on evaluating 
CgA, known as a stress marker, in dogs suffering from infection. However, the 
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results were somewhat unexpected, because they were not similar to other 
studies in humans where increased circulating CgA was found in critically ill 
and intensive care patients with severe sepsis (Rosjo et al., 2012; Zhang et al.,
2009). An explanation for this difference could be that most pyometra dogs in 
our study were not suffering from as severe sepsis, and had shown clinical 
signs within two weeks before admission at UDS as mentioned in Paper I (i.e.
possibly less acute disease). Another explanation could be that a negative 
feedback control of Cst leads to inhibited secretion of catecholamines and 
CgA, and subsequently decreased CgA concentrations. In humans, the Cst is a 
potent and specific cholinergic antagonist in chromaffin cells, and increased 
Cst concentration could inhibit catecholamine secretion (Taupenot et al., 2000; 
Mahata et al., 1997). Such negative feedback would be more likely to occur in 
individuals with chronic (pyometra) as opposed to acute disease (severe illness 
or sepsis in the studied human patients). There may also be species differences 
or methodological differences that could be overlooked.
Why Cst concentrations but not VS concentrations were decreased remains 
to be determined. The relation between intact CgA and its fragments is 
complex and although this has not been shown, one possible explanation of the 
differences found between Cst and VS could be that Cst measurement 
comprises both intact CgA and Cst as well as other possible fragments of CgA 
that contain the Cst part. Because the assay is expressed in molar units it 
measures the number of molecules present in the sample i.e. the assay most 
probably measures the total CgA content. The same is true for VS 
measurements with the currently used assay, but when comparing results from 
these two assays (Cst and VS), diverging results were found. Other
explanations for the different results of the two derived CgA in our study, 
would be because of a variety of post-transitional cleavages and the difference 
of its biologically active peptides (Helle et al., 2007). However, more studies 
in dogs are needed to gain further information.
A method to measure the entire molecule of CgA in dogs is currently not 
commercially available. Methods used to detect CgA in humans vary and 
different peptides have been measured, which should be considered when 
comparing the results of different clinical studies (Biswas et al., 2010; Mazza
et al., 2010; Stridsberg et al., 2003). The results of Cst in our study are 
promising and indicate that Cst might be useful as a marker for CgA in a 
variety of diseases in dogs. Measurement of CgA could be valuable not only 
for dogs with infection but also with neuroendocrine tumours because CgA has 
been shown to be an excellent marker for neuroendocrine tumours in humans 
(Ferrari et al., 2004; Oconnor & Bernstein, 1984). Whether CgA and its break-
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down products Cst and VS are useful as biomarkers for diagnostic purposes or 
prognostication in dogs, remains to be further discovered.
4.5 Can sepsis be identified in pyometra?
Sepsis, i.e. SIRS-positive status, was found in nearly 75% of the studied dogs 
with pyometra (Paper III). The two major APPs and other variables were 
investigated for possible association with sepsis and SAA concentrations were 
significantly increased in pyometra dogs with sepsis. For SAA, the receiver 
operating characteristic curve (ROC) analysis displayed an area under the 
curve (AUC) of 0.74 in dogs with sepsis (P = 0.04). The specificity and 
sensitivity for detection of dogs with sepsis by SAA analysis was not very high 
(74% and 50% respectively) using a selected cut-off value at 109.07 mg/L. 
This means that one-fourth of dogs without sepsis would be falsely classified 
as septic dogs and, worse, truly septic dogs would be classified as non-septic, 
making SAA unsuitable as a sole marker for sepsis. Concentrations of CRP and 
albumin were not significantly different in dogs with or without sepsis 
according to the criteria selected. These results point to a possible higher 
clinical value for SAA in the detection of sepsis compared to CRP, and this 
potential deserves to be further investigated.
The finding that SAA possibly had a better clinical value compared to CRP 
is in line with other studies in which SAA has shown more promise as a 
diagnostic marker than CRP for the diseases linked with inflammation, even 
though there was some overlapping (Christensen et al., 2014; Christensen et 
al., 2013). In human medicine, SAA has been shown to be a better prognostic 
marker for severity of cancer associated with inflammation (Wang et al., 2012; 
Zhang et al., 2012; Cho et al., 2010; Kosuge et al., 2007) and for prediction of 
outcome in non-ST-segment elevation acute coronary syndromes (Kosuge et 
al., 2007). Although both CRP and SAA are major APPs in dogs, the roles and 
abilities as biomarkers may differ, indicating that there may be conditions or 
diseases for which SAA could have a clinically higher diagnostic or prognostic 
value than the more frequently used CRP. Alternatively, that a panel of several 
APPs combined with other analyses with different abilities will be more 
optimal for diagnosis or prognostication.
Concentrations of CRP and albumin did not differ between septic and non-
septic dogs although albumin concentrations were decreased and CRP 
increased in most bitches with pyometra compared to healthy dogs (Paper II, 
III). CRP was not associated with sepsis which is in contrast to a previous 
report (Fransson et al., 2007). This difference between studies could be 
because of methodological differences, individual variation/severity of 
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systemic inflammation in the dogs included in the two studies that larger study 
is necessary to show this association. Concentrations of albumin were also not 
significantly different in bitches with or without sepsis. This finding was 
unforeseen because lower albumin concentrations have been reported in sepsis 
and circulating albumin decreases in experimentally induced endotoxaemia in 
dogs, cats and rats (Greiner et al., 2008; Deysine & Stein, 1980; Powanda et 
al., 1972). However, the clinical situation is different from experimental 
studies in that the studied dogs were admitted at various stages of disease 
progression and the effect of endotoxaemia may therefore vary. CRP and 
albumin might still have a diagnostic value in dogs with pyometra and more 
severe disease (septic peritonitis or septic shock), but this needs to be further 
studied.
4.6 To spay or not to spay? Considerations based on breed 
differences in disease occurrence
The development of pyometra depends on several factors, of which breed is 
one of the most important for predicting the risk for developing the disease.
The risk for developing both pyometra and MTs varied considerably between 
breeds as shown in Paper V. The risk of developing both these diseases was 
high in several large or giant breed dogs and also increased with increasing age 
(Table 1). Although reproductive hormones may be involved to some extent in 
the development of both diseases, the high risk breeds differed, as illustrated 
by the 10 breeds with the highest risk of developing either pyometra or MTs or 
both pyometra and MTs up to 10 years of age (Table 1). This means that 
different factors are likely to be involved in the pathogenesis. The 10 breeds
with highest risk to be diagnosed with either or both of the two diseases were 
Leonberger (73%), Irish Wolfhound (69%), Bernese Mountain Dog (69%), 
Great Dane (68%), Staffordshire Bull Terrier (66%), Rottweiler (65%), Bull
Terrier (62%), Doberman (62%), Bouvier des Flandres (60%) and Airdale
Terrier (60%) (Table 1). 
Disease occurrence differed greatly among breeds, which is why breed is an 
important factor to consider when predicting the risk for pyometra in dogs on 
an individual basis. The breeds with highest risk of developing pyometra 
(proportion (%) by 10 years of age) included Bernese Mountain Dog (66%), 
Great Dane (62%), Leonberger (61%), Rottweiler (58%), Irish Wolfhound 
(58%), Staffordshire Bull Terrier (54%), Keeshond (52%), Bull Terrier (52%), 
Bouvier des Flandres (50%), and Newfoundland (50%) (Table 1).
Meanwhile, Finnish Spitz (3%), Norrbotten Spitz (4%), Coton de Tulear 
(5%), Maltese (8%), Gordon Setter (8%), Laika (8%), Saluki (10%), Tibetan 
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Terrier (10%), Lancashire Bull Terrier (10%) and Norwich Terrier (11%) were 
the breeds that had the lowest risk of developing pyometra (Table 1).
Indications for neutering/spaying healthy female dogs include pet 
overpopulation, owner convenience reasons, behaviour-related issues, 
contraception and disease prevention (Reichler, 2009; Rupprecht et al., 2006; 
Blackshaw & Day, 1994). Possible health benefits of neutering female dogs are
prevention of the common uterine diseases, such as cystic endometrial 
hyperplasia and pyometra, especially in high-risk breeds. Additionally, oestrus-
cycle associated disorders such as severe overt pseudo-pregnancy and ovarian 
cysts are prevented by OHE (Akihara et al., 2007; Patnaik & Greenlee, 1987; 
Bishop, 1972; Krook et al., 1960). The risk of other diseases induced by 
reproductive hormone production such as neoplasia of the mammary glands 
(Schneider et al., 1969) and genital tract, progestagen-induced diabetes type 2 
and growth hormone excess is also reduced in neutered animals (Fall et al.,
2007; Eigenmann et al., 1983). The age at which spaying is performed may 
influence the protective effect as shown by dogs neutered at an early age 
(before 1st oestrus) having a lower risk of developing malignant MTs (0.5%) 
which increased to 8% when neutering was performed at 2nd oestrus and 26% 
at any oestrus thereafter (Schneider et al., 1969). Our results showed that the 
proportion of dogs developing pyometra and MTs increased by age (Table 1).  
Spaying female dogs has been associated with some negative side-effects 
such as urinary incontinence, vaginitis, overweight, altered consistency of the 
coat and behavioural changes (Belsito et al., 2009; Slauterbeck et al., 2004; 
Cooley et al., 2002; Hart, 2001; Sorenmo et al., 2000). These side-effects can 
be serious and may lead to euthanasia if non-responsive to treatment (Arnold et 
al., 1996). Urinary incontinence may be incurable and neutering was shown to 
lead to acquired urinary incontinence in nearly 10% of the studied bitches in 
one report (Stocklin-Gautschi et al., 2001). The occurrence of urinary 
incontinence after neutering/spaying also varies greatly with breed, being more 
frequent in large breed dogs, i.e. individuals with a weight of over 20 kg
(Stocklin-Gautschi et al., 2001; Arnold et al., 1989). Additionally, in one study 
the Boxer breed was shown to have high risk (65%) of developing urinary 
incontinence after spaying (Arnold et al., 1989). Some large or giant breed 
dogs that have high risk of developing pyometra thus also have increased risk 
for acquiring urinary incontinence after spaying according to the results of 
other studies, as shown in Table 2. However, the occurrence of the unwanted 
side effects may also differ depending on the age at which age the spaying is 
performed (Stocklin-Gautschi et al., 2001).
Neutered dogs are more likely to become overly overweight (Lund et al.,
2006), and obesity may in turn increase the risk for diseases such as diabetes 
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mellitus (DM) (German, 2006; Lund et al., 2006). In contrast, one other study 
indicated that spaying was not associated with an increased risk of developing 
DM (Mattin et al., 2014). Several factors influence the risk of DM including 
breed (Fall et al., 2007), administered drugs or hormones (e.g. progesterone) 
(Krook et al., 1960; Wilkinson, 1960). Neutering prevents the development of 
pyometra but the interrelationship between obesity, DM and the disease is 
complex and not yet clarified.
Neutered dogs have a higher risk of developing neoplastic conditions such 
as osteosarcoma and haemangiosarcoma (Smith, 2014). The risk of developing 
osteosarcoma was reported to be increased nearly two times in neutered dogs 
(Ru et al., 1998). It has also been indicated that spayed dogs live longer than 
intact female dogs (Hoffman et al., 2013; Michell, 1999). Because malignant 
diseases are more common in old dogs, the fact that neutered dogs live longer 
than intact female dogs might explain why some malignant diseases are more 
common in neutered dogs (Hoffman et al., 2013). However, in another study, 
neutering at younger age (< 4 years of age) led to a shorter life span than when 
neutering was performed after four years of age (Waters et al., 2009).
Oestrogens enhance the immune response (Cutolo et al., 2004) and have anti-
oxidative stress properties (Borras et al., 2003) which has been suggested to be 
one reason why women live longer than men (Austad, 2006). However, many 
factors might influence life expectancy and the role of oestrogen in dogs and its 
relationship with longevity is not yet clarified.
In conclusion, whether a bitch should be spayed or not is disputable, and 
there are many factors to consider. Health benefits and unwanted side-effects 
of spaying in the short- and long-term are known to differ by breed and may 
also depend on the age at which the procedure is performed. These factors and 
possible effects for each individual dog should be discussed with the owner to 
make the optimal choice for each bitch. 
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Table 1. Proportion of bitches that had developed either mammary tumour (MT) or pyometra, or 
both diseases separately as illustrated in different breeds at < 10 years of age, < 8 years of age 
and < 6 years of age in insurance data from 1995-2006
Variable Proportion (%) at different age
< 10 years < 8 years < 6 years
Either MT or pyometra or both 
diseases
Breed at high risk at < 10 years of age
   Leonberger 73 46 16
   Irish Wolfhound 69 46 17
   Bernese Mountain Dog 69 50 28
   Great Dane 68 54 33
   Staffordshire Bull Terrier 66 43 30
   Rottweiler 65 43 20
   Bull Terrier 62 39 24
   Doberman Pinscher 62 37 21
   Bouvier des Flandres 60 34 15
   Airedale Terrier 60 26 6
Breed at low risk at < 10 years of age 
   Finnish Spitz 9 3 1
   Laika 10 9 4
   Norwich Terrier 11 8 5
   Lancashire Bull Terrier 12 7 5
   Norrbotten Spitz 14 5 1
   Finnish Lapphund 15 10 3
   Basenji 16 13 10
   Greyhound 16 10 5
   Tibetan Spaniel 18 9 4
   Siberian Husky 18 12 5
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Table 1 cont’d.
Pyometra
Breed at high risk at < 10 years of age
   Bernese Mountain Dog 66 50 28
   Great Dane 62 51 31
   Leonberger 61 41 15
   Rottweiler 58 42 20
   Irish Wolfhound 58 34 17
   Staffordshire Bull Terrier 54 40 27
   Keeshond 52 29 14
   Bull Terrier 52 35 20
   Bouvier des Flandres 50 33 15
   Newfoundland 50 37 16
Breed at low risk at < 10 years of age
   Finnish Spitz 3 2 1
   Norrbotten Spitz 4 2 1
   Coton de Tulear 5 5 5
   Maltese 8 2 0
   Gordon Setter 8 5 5
   Laika 8 7 4
   Saluki 10 8 4
   Tibetan Terrier 10 6 3
   Lancashire Bull Terrier 10 7 5
   Norwich Terrier 11 8 5
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Table 1 cont’d.
MT
Breed at high risk at < 10 years of age
   Leonberger 46 27 8
   Doberman Pinscher 42 20 7
   Irish Wolfhound 41 33 4
   Welsh Terrier 37 12 0
   English Springer Spaniel 36 17 4
   American Cocker Spaniel 35 17 4
   Boxer 35 16 6
   Bedlington Terrier 33 11 4
   Old English Sheepdog 29 13 2
   Softcoated Wheaten Terrier 28 14 5
Breed at low risk at < 10 years of age
   Norwich Terrier 1 0 0
   Collie 2 1 0
   Lancashire Bull Terrier 2 0 0
   Laika 2 2 0
   Pug 3 3 1
   Finnish Lapphund 3 1 0
   Buhund 4 2 1
   Pomeranian 4 2 1
   Siberian Husky 5 3 0
   Basenji 5 2 2
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Table 2. The top 10 breeds with highest risk of developing pyometra up to 10 years of age 
illustrated together with dogs breeds at increased risk of developing urinary incontinence after 
spaying according to other studies. 
Pyometra Acquired urinary incontinence¶
Bernese Mountain Dog Weimaraner¶
Great Dane Doberman Pincher¶
Leonberger Old English Sheepdog¶
Rottweiler Rottweiler¶
Irish Wolfhound Boxer*
Staffordshire Bull Terrier Irish Setter¶
Keeshond
Bull Terrier
Bouvier des Flanders
Newfoundland
¶Holt and Thrusfield, 1993; *Arnold et al., 1989 
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5 Conclusions
¾ Several routinely explored clinical and laboratory findings such as 
leucopaenia, moderate to severe depression of the general condition, pale 
mucous membranes, fever or hypothermia were useful as markers to 
predict peritonitis and/or outcome as measured by prolonged postoperative 
hospitalisation after surgical treatment. Leucopaenia was the most
important predictive variable, associated with both increased risk for 
peritonitis and prolonged postoperative hospitalisation. 
¾ Concentrations of IGF-I and iron were decreased in pyometra, whereas 
concentrations of CRP and SAA were increased. Although unspecific, 
these variables might be helpful in the diagnosis of pyometra if used 
together with other clinical parameters.
¾ Concentrations of SAA were higher in dogs with pyometra that also were 
diagnosed with sepsis. This indicates that SAA might be clinically useful 
as a biomarker to aid in the differentiation of septic versus non-septic dogs. 
¾ Concentrations of CRP and albumin did not differ between septic and non-
septic dogs and were therefore not valuable as markers for sepsis.
¾ Catestatin concentrations were decreased in dogs with pyometra, whereas 
concentrations of VS were not significantly affected by the disease. These 
findings indicate a possible neuroendocrine response in pyometra. To 
evaluate the potential of CgA and its breakdown products as biomarkers, 
further studies are needed.
¾ None of the inflammatory variables investigated (CRP, SAA, albumin, 
iron, IGF-I) or CgA breakdown products (Cst and VS) were useful in the 
prediction of outcome as measured by postoperative hospitalisation. 
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¾ The occurrence of pyometra and MTs was investigated in female dogs of 
110 different breeds, and was shown to vary greatly between different 
breeds. In 20 dog breeds, over 50% of the bitches had developed either 
pyometra or MTs or both diseases before 10 years of age. These findings 
show that breed is an important factor for predicting the risk of these 
diseases in individual dogs.
¾ Spaying is associated with possible health benefits as well as unwanted 
side-effects, and these differ by breed. The breed-specific data of pyometra 
and MTs presented in this thesis may be valuable when deciding whether 
or not to perform elective spaying in individual dogs of different breeds.
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6 Future perspectives
Biomarkers are gaining increasing interest in both human and veterinary 
medicine i.e. for diagnostic purposes and to predict outcome by hospitalisation 
or survival. Early recognition of disease and appropriate treatment is crucial, 
especially for severely ill patients. Clinically useful biomarkers that can be 
helpful for diagnosis and prognostication will be most valuable, and this area 
needs to be studied further.
The mechanisms involved in the response to sepsis and the progression of 
severe bacterial infection is complicated. Because pyometra is caused by a 
bacterial infection, is treated by surgery and often leads to sepsis, the disease
may serve as a model for studying surgical sepsis. The results of such studies 
are most likely applicable for sepsis induced also by other diseases or surgical 
procedures. Because dogs have similar inflammatory responses as humans, 
studying dogs that are surgically treated will provide a spontaneous disease 
model for surgical sepsis that is more similar to the real-life situation at 
veterinary and human hospitals than experimental research studies. Further 
studies on predictive markers for outcome in septic patients suffering from a 
variety of diseases will be most valuable clinically. Studies of dogs with 
pyometra could be helpful to identify early diagnostic and prognostic markers, 
and also for evaluating novel therapies or therapeutic strategies for sepsis.
So far there are no single or specific biomarkers available for diagnosing 
pyometra or for predicting the severity of the disease. Further studies in this 
area, and of panels of several biomarkers combined for the same purposes, are 
therefore needed. Other than establishing predictive or diagnostic markers,
there is also a demand for increased knowledge about possible novel ways for 
preventing the development of pyometra.
Dogs with sepsis need to be recognised as early as possible, especially 
when requiring surgery which may be associated with high risk of life-
threatening complications or death. There are no specific markers that can be 
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used for early diagnosis or prediction of sepsis in dogs. In human medicine, 
several biomarkers have been investigated, but many interesting variables still 
remain to be explored in dogs. Moreover, genetic factors are likely to 
predispose and/or to protect development of pyometra, as shown by the great 
breed differences in occurrence. It would be interesting to investigate possible
genetic factors as well as up- and downregulated genes and products of the 
upregulated genes in the circulation, to identify novel diagnostic or prognostic 
markers and new targets for treatment of the disease.
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